This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Millennium Pharmaceuticals Limited, Wyeth. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 855 
4 out of 1,309 
Years Active: 2006-2010
Title: Maria Blatcher: Innovator in PYRIN Protein Research
Introduction
Maria Blatcher is a prominent inventor based in Moorestown, NJ (US). She has made significant contributions to the field of molecular biology, particularly in the study of the PYRIN/NBS/LRR protein family. With a total of 4 patents to her name, her work has implications for diagnostic and therapeutic methods.
Latest Patents
Her latest patents focus on the novel PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, and PYRIN-11 polypeptides, proteins, and nucleic acid molecules. These inventions include isolated proteins, fusion proteins, antigenic peptides, and antibodies targeting these specific PYRIN proteins. Additionally, her patents cover nucleic acid molecules, recombinant expression vectors, and non-human transgenic animals that have been genetically modified to include or disrupt these genes. The diagnostic, screening, and therapeutic methods utilizing her compositions further enhance the potential applications of her research.
Career Highlights
Throughout her career, Maria has worked with notable companies such as Wyeth and Millennium Pharmaceuticals Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include John Bertin and Weiye Wang, who have also made significant contributions to the field of molecular biology.
Conclusion
Maria Blatcher's innovative work in the PYRIN protein family exemplifies the impact of dedicated research in advancing medical science. Her patents and collaborations highlight her commitment to improving diagnostic and therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile